Cardiometrics
This article was originally published in The Gray Sheet
Executive Summary
Receives a $3.1 mil. new equity financing through an investment in series D preferred stock by Goodman Company, Ltd. of Japan. Privately held Cardiometrics says the funding will facilitate additional clinical trials of its FloWire functional angiometry guidewire and its SmartWire guidewire for measuring blood flow changes in the cerebral vasculature. The funds will also enable Cardiometrics to "expand development efforts on related products," the Mountain View, California-based company says